Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Jeff Chan who wrote (1604)	4/8/1999 7:39:00 PM
From: the Chief	Read Replies (1) \| Respond to of 14101

So Jeff, what is your impression of the answers given?(eom)

To: Jeff Chan who wrote (1604)	4/8/1999 9:40:00 PM
From: DaveAu	Respond to of 14101

Thanks for posting that Jeff. Thanks to Peter Block for giving such a detailed answer. I'm holding tight. I don't believe it matters whether a deal is done by the end of May or not. It's not written in stone. What really matters is FDA approval. The people who are selling now are not insiders. They are small time investors who are probably chasing the internuts. BJ

To: Jeff Chan who wrote (1604)	4/9/1999 6:53:00 AM
From: Mark Bartlett	Respond to of 14101

Jeff, Thanks for posting Peter's response. The decision not to publish study #107-96 was, IMO, a calculated one, weighing two outcome events - i.e., gaining credibility in a peer reviewed journal vs. keeping the research data in-house. I suspect keeping the nature of the research quiet was, in their view, the more important of the two, given the fact that in the end the regulatory agencies would ultimately decide how good the data was. Very much the nature of the way this company has worked. Really nice to have a pharmacist on this thread ... I know a doctor or two that post here under pseudonymns too. Best to all, MB